Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

作者信息

Murphy Robin J, Sumner Rachael L, Evans William, Menkes David, Lambrecht Ingo, Ponton Rhys, Sundram Frederick, Hoeh Nicholas, Ram Sanya, Reynolds Lisa, Muthukumaraswamy Suresh

机构信息

School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand.

Mana Health, 7 Ruskin St, Parnell, Auckland, 1052, New Zealand.

出版信息

Trials. 2021 May 10;22(1):334. doi: 10.1186/s13063-021-05307-4.

DOI:10.1186/s13063-021-05307-4

PMID:33971929

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8108445/

Abstract

摘要

相似文献

Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Trials. 2021 May 10;22(1):334. doi: 10.1186/s13063-021-05307-4.

MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Trials. 2021 Apr 23;22(1):302. doi: 10.1186/s13063-021-05243-3.

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.

Lancet. 2016 Nov 5;388(10057):2239-2253. doi: 10.1016/S0140-6736(16)31009-1. Epub 2016 Sep 21.

Correction to: The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.

Psychopharmacology (Berl). 2020 Dec;237(12):3803. doi: 10.1007/s00213-020-05682-x.

Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.

J Neuroendocrinol. 2016 Mar;28(3):12374. doi: 10.1111/jne.12374.

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial.

Lancet. 2019 Dec 22;392(10165):2718-2727. doi: 10.1016/S0140-6736(18)32488-7. Epub 2018 Nov 5.

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.

Lancet. 2015 Aug 15;386(9994):680-90. doi: 10.1016/S0140-6736(15)60732-2. Epub 2015 Jun 15.

Randomised double masked trial comparing the efficacy and tolerance of 0.05% mequitazine eye drops versus 0.05% levocabastine and placebo in allergic conjunctivitis induced by a conjunctival provocation test with Dermatophagoides pteronyssinus.

Br J Ophthalmol. 2004 Mar;88(3):336-40. doi: 10.1136/bjo.2003.021907.

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet. 2017 Feb 11;389(10069):621-628. doi: 10.1016/S0140-6736(16)32617-4. Epub 2016 Dec 23.

A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.

Trials. 2017 Mar 16;18(1):128. doi: 10.1186/s13063-017-1861-3.

本文引用的文献

MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Trials. 2021 Apr 23;22(1):302. doi: 10.1186/s13063-021-05243-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验